Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 7 (12), e50836

Association Between Proton Pump Inhibitor Therapy and Clostridium Difficile Infection: A Contemporary Systematic Review and Meta-Analysis

Affiliations
Review

Association Between Proton Pump Inhibitor Therapy and Clostridium Difficile Infection: A Contemporary Systematic Review and Meta-Analysis

Imad M Tleyjeh et al. PLoS One.

Abstract

Introduction: Emerging epidemiological evidence suggests that proton pump inhibitor (PPI) acid-suppression therapy is associated with an increased risk of Clostridium difficile infection (CDI).

Methods: Ovid MEDLINE, EMBASE, ISI Web of Science, and Scopus were searched from 1990 to January 2012 for analytical studies that reported an adjusted effect estimate of the association between PPI use and CDI. We performed random-effect meta-analyses. We used the GRADE framework to interpret the findings.

Results: We identified 47 eligible citations (37 case-control and 14 cohort studies) with corresponding 51 effect estimates. The pooled OR was 1.65, 95% CI (1.47, 1.85), I(2) = 89.9%, with evidence of publication bias suggested by a contour funnel plot. A novel regression based method was used to adjust for publication bias and resulted in an adjusted pooled OR of 1.51 (95% CI, 1.26-1.83). In a speculative analysis that assumes that this association is based on causality, and based on published baseline CDI incidence, the risk of CDI would be very low in the general population taking PPIs with an estimated NNH of 3925 at 1 year.

Conclusions: In this rigorously conducted systemic review and meta-analysis, we found very low quality evidence (GRADE class) for an association between PPI use and CDI that does not support a cause-effect relationship.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow diagram of eligible studies.
Figure 2
Figure 2. Forest Plot of the Meta analyses of The Association Between CDI and Proton Pump Inhibitors Based on 51 Observations.
Figure 3
Figure 3. Contour enhanced funnel plot of the association between the effect-estimates and its standard errors:
* Contour enhanced funnel plots with implementation of regression adjustment model (adjusted effect at top where SE is 0).* The contour lines differentiate the significance and non-significance regions in the plot at 1%, 5% and 10% significance levels. *Vertical lines show average effect-estimates from random effect (red), and fixed effect models (blue). *A regression line (black) is added for regression based adjustment (With adjusted effect estimate and 95% CI at top where SE is 0). Abbreviations: FEMA: Fixed effect meta-analysis, REMA: Random effect meta-analysis, Reg: Regression line.
Figure 4
Figure 4. Influence of a hypothetical dichotomous confounder present in 20% (panel A) and 50% (panel B) of the study population, unaccounted for in the adjustments already performed in the individual studies.
The graphs indicate what combinations of OREC and RR that would be necessary for the confounder to fully account for the observed association between proton pump inhibitor (PPI) use and CDAD after adjustment for publication bias. Abbreviations: OREC, odds ratio of exposure to the confounder in PPI non-users vs. acid-suppression users; RRCD, relative risk of CDAD in individuals exposed to the confounder vs. non-exposed.

Similar articles

See all similar articles

Cited by 44 PubMed Central articles

See all "Cited by" articles

References

    1. IMS Health (2005) Leading 20 therapeutic classes by U.S. sales, Available: http: //www.imshealth.com/ims/portal/front/articleC/0,2777,6599_73915261_77140565,00.html. Accessed 2006 June.
    1. Yachimski PS, Farrell EA, Hunt DP, Reid AE (2010) Proton Pump Inhibitors for Prophylaxis of Nosocomial Upper Gastrointestinal Tract BleedingEffect of Standardized Guidelines on Prescribing Practice. Arch Intern Med. 2010 170(9): 779–783. - PMC - PubMed
    1. Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL (2007) Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 83: 66–68. - PMC - PubMed
    1. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, et al. (2010) Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 69(5): 543–552. - PMC - PubMed
    1. Mat Saad AZ, Collins N, Lobo MM, O’Connor HJ (2005) Proton pump inhibitors: a survey of prescribing in an Irish general hospital. Int J Clin Pract 59: 31–34. - PubMed

Substances

Grant support

The authors have no funding or support to report.
Feedback